Abstract # 1001 Phase 1 TITE-CRM Dose Escalation Study Of Concurrent Temozolomide And Intensity Modulated Radiation Therapy In Newly Diagnosed Glioblastoma Multiforme

Presenter: Doris Brown, MD, PhD




Click on images to enlarge (a new pop-up window will open)

Poster: